A Post-Marketing Surveillance of the Abuse of Eluxadoline using Poison Centre Data in the United States and Canada

22/08/2018
14/03/2024
EU PAS number:
EUPAS25247
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Poison Center Eluxadoline Study Protocol 07AUG2018_Redacted

English (486.39 KB - PDF) View document
Study results
Study results

RADARS System Allergan EUPAS 25247 2019_Abstract

English (270.55 KB - PDF) View document
Study report
Other information
Study, other information

RADARS System Annual Study Report Allergan 2018_Abstract

English (29.44 KB - PDF) View document

Truberzi Canada_RADARS System (1st Interim Report Abstract)

English (28.16 KB - PDF) View document